Paul W. Sandman, Director at PDL BIOPHARMA, INC. (PDLI), bought 10,000 shares at $7.38 ($74K) on 2009-04-08, disclosed to the SEC on 2009-04-13.
Open-market purchase of $74k PDLI by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.